Synteract Inks Buy of Harrison Clinical

Synteract, which is backed by Gryphon Investors, has agreed to buy Harrison Clinical Research. Financial terms were not announced. Munich, Germany-based Harrison is a clinical research company.

DealsNorth AmericaUSBriefs